Transitioning to the stage 2 dose of Tirzepatide between weeks 5 to 8 marks a crucial phase in your weight management journey. Having progressed from the starting dose, this phase builds upon the groundwork laid earlier. Tirzepatide continues its partnership with your body, harnessing the effects of GIP (Gastric inhibitory polypeptide) and GLP-1 (glucagon‐like peptide) hormones and to sustainably manage blood sugar levels, insulin production, and hunger signals.